Effect of CYP2C19*2 and *3 Loss-of-Function Alleles on Platelet Reactivity and Adverse Clinical Events in East Asian Acute Myocardial Infarction Survivors Treated With Clopidogrel and Aspirin
Author(s) -
YoungHoon Jeong,
Udaya S. Tantry,
InSuk Kim,
Jin-Sin Koh,
Tae Jung Kwon,
Yongwhi Park,
Seok-Jae Hwang,
Kevin P. Bliden,
Choong Hwan Kwak,
JinYong Hwang,
Paul A. Gurbel
Publication year - 2011
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.111.962555
Subject(s) - medicine , clopidogrel , myocardial infarction , cyp2c19 , adverse effect , cardiology , platelet , acute coronary syndrome , p2y12 , cytochrome p450 , metabolism
As compared with whites, East Asians more often carry the cytochrome P450 (CYP) 2C19 loss-of-function (LOF) allele with the CYP2C19*3 variant. The influence of the CYP2C19 LOF alleles (*2 and *3) on clopidogrel response and clinical outcomes in East Asians with acute myocardial infarction (AMI) has not been reported. We sought to evaluate the effect of the CYP2C19 variants on clopidogrel pharmacodynamics and long-term prognosis in these patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom